| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.03 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |